tiprankstipranks
Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
US Market
Holding COEP?
Track your performance easily

Coeptis Therapeutics Holdings (COEP) Income Statement

102 Followers

Coeptis Therapeutics Holdings Income Statement

Last quarter (Q ), Coeptis Therapeutics Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Coeptis Therapeutics Holdings's net income was $-1.83M. See Coeptis Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 75.00K-$ 0.00
Cost of Revenue
----$ 964.22K-
Gross Profit
---$ 75.00K$ -933.46K-
Operating Expense
$ 11.46M$ 21.49M$ 34.20M$ 14.53M$ 68.43K$ 2.23K
Operating Income
$ -11.46M$ -21.49M$ -34.20M$ -14.46M$ -68.43K$ -2.23K
Net Non Operating Interest Income Expense
$ -280.39K$ -107.69K$ -218.41K$ -187.13K$ 1.20K$ 0.00
Other Income Expense
$ 34.59K$ 332.27K$ -3.16M$ -196.91K$ 17.10M-
Pretax Income
$ -11.89M$ -21.27M$ -37.57M$ -13.45M$ -17.17M$ -2.23K
Tax Provision
--$ -24.02K$ -2.30M--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -11.89M$ -21.27M$ -37.57M$ -13.45M$ -9.16M$ -2.23K
Basic EPS
$ -0.25$ -0.83$ -2.63$ 1.62-$ >-0.01
Diluted EPS
$ -0.25$ -0.83$ -2.63$ 1.62$ -0.03$ >-0.01
Basic Average Shares
$ 147.14M$ 25.69M$ 14.30M$ 7.50M$ 1.97M$ 9.66M
Diluted Average Shares
$ 147.14M$ 25.69M$ 14.30M$ 7.50M$ 1.97M$ 9.66M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 24.41M$ 21.49M$ 34.20M$ 14.53M$ 68.43K$ 2.23K
Net Income From Continuing And Discontinued Operation
$ -11.71M$ -21.27M$ -37.57M$ -13.45M$ -9.16M$ -2.23K
Normalized Income
$ -7.99M$ -16.80M---$ -2.23K
Interest Expense
------
EBIT
$ -11.61M$ -21.16M$ -37.36M$ -13.26M$ -9.01M$ -2.23K
EBITDA
$ -10.43M$ -20.16M$ -36.35M$ -12.81M$ -8.68M$ -2.23K
Currency in USD

Coeptis Therapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis